PM14 Administered Intravenously to Patients With Advanced Solid Tumors
NCT05076396
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
126
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
PM14
Sponsor
PharmaMar